Press & Media Center

The latest news and resources from Celljevity

Media Inquiries Download Media Kit

Recent Press Releases

Stay updated on our latest announcements and breakthroughs

January 30, 2025

Celljevity Advances Autologous Cell Therapy Platform

Revolutionary approach using patients' own cells shows promise across multiple age-related conditions.

January 15, 2025

Understanding the Science Behind Telomere Extension

Celljevity scientists explain how cellular rejuvenation works at the molecular level.

December 1, 2024

Celljevity Expands Research into Cellular Regeneration

New studies explore the potential of resetting biological clocks through proprietary cell therapy.

November 10, 2024

Prometheus Cell Therapy: From Myth to Medical Reality

How ancient mythology inspired modern regenerative medicine breakthroughs.

View All News

Company Overview

Key facts and figures about Celljevity

2021

Founded

Los Angeles, CA

Headquarters

150+

Employees

Clinical Sites

1,000+

Patients Treated

95%

Success Rate

About Celljevity

Celljevity is a pioneering biotechnology company specializing in cellular regeneration through proprietary autologous cell technology. Founded in 2021, we are dedicated to revolutionizing the field of regenerative medicine by developing treatments that reverse cellular aging at its source.

Our groundbreaking autologous rejuvenated fibroblast (auto-rFib) technology represents a paradigm shift in anti-aging medicine. By harvesting, rejuvenating, and reintroducing patients' own cells, we achieve unprecedented results in cellular renewal without the risks associated with traditional approaches.

With successful clinical trials demonstrating 95% patient satisfaction rates and measurable improvements in cellular health markers, Celljevity is positioned at the forefront of the longevity revolution. Our mission is to make cellular rejuvenation accessible to those seeking to optimize their healthspan and maintain vitality throughout their lives.